ParaPRO
Pre-clinicalParaPRO brings innovative therapies to market that address the personal and public health concerns caused by infestations such as head lice and scabies in the age of resistance.
Founded
1999
Focus
Small Molecules
About
ParaPRO brings innovative therapies to market that address the personal and public health concerns caused by infestations such as head lice and scabies in the age of resistance.
Funding History
2Total raised: $25M
Series B$15MUndisclosedJun 15, 2007
Series A$10MUndisclosedJun 15, 2005
Company Info
TypePrivate
Founded1999
LocationCarmel, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile